These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 4425061)
21. [Pharmaccokinetics of various antibiotics on mucoviscidosis with special reference to their concentration in sputum in relation to its chemical composition]. Bonomi U; Marcer V; Piacentini I; Bravi A; Battaglino G; Stizzoli R; Mastella G Fracastoro; 1970; 63(3):579-609. PubMed ID: 5517030 [No Abstract] [Full Text] [Related]
22. Doubts and water droplets in mist therapy. Baker H Pediatrics; 1969 Feb; 43(2):304-5. PubMed ID: 5763870 [No Abstract] [Full Text] [Related]
23. Use of ultrasonic aerosols with ventilatory assistors. Miller WF; Johnston FF; Tarkoff MP J Asthma Res; 1968 Jun; 5(4):335-54. PubMed ID: 4299010 [No Abstract] [Full Text] [Related]
24. Effects of ultrasonically nebulized distilled water on airway dynamics in children with cystic fibrosis and asthma. Barker R; Levison H J Pediatr; 1972 Mar; 80(3):396-400. PubMed ID: 5060455 [No Abstract] [Full Text] [Related]
30. Doubts and water droplets in mist therapy. Matthews LW; Doershuk CF Pediatrics; 1969 Feb; 43(2):305-6. PubMed ID: 5763871 [No Abstract] [Full Text] [Related]
31. Sputum viscosity and pulmonary function in cystic fibrosis. Feather EA; Russell G Arch Dis Child; 1970 Dec; 45(244):807-8. PubMed ID: 5491885 [No Abstract] [Full Text] [Related]
32. Late effect of nocturnal mist tent therapy related to the severity of airway obstruction in children with cystic fibrosis. Bureau MA; McDougall DM; Beaudry PH; Belmonte MM Pediatrics; 1978 Jun; 61(6):842-6. PubMed ID: 673547 [TBL] [Abstract][Full Text] [Related]
33. Treatment of mucus hypersecretion in human disease. Reid L Adv Exp Med Biol; 1977; 89():469-76. PubMed ID: 930734 [No Abstract] [Full Text] [Related]
34. Revisited physicochemical and transport properties of respiratory mucus in genotyped cystic fibrosis patients. Deneuville E; Perrot-Minot C; Pennaforte F; Roussey M; Zahm JM; Clavel C; Puchelle E; de Bentzmann S Am J Respir Crit Care Med; 1997 Jul; 156(1):166-72. PubMed ID: 9230742 [TBL] [Abstract][Full Text] [Related]
35. In vivo penetration of antibiotics into sputum in cystic fibrosis. Saggers BA; Lawson D Arch Dis Child; 1968 Aug; 43(230):404-9. PubMed ID: 4969417 [No Abstract] [Full Text] [Related]
36. The Mist Tent: An Analysis of Therapeutic Change in the History of Cystic Fibrosis Care. Labonte ML Bull Hist Med; 2018; 92(4):634-663. PubMed ID: 30613046 [TBL] [Abstract][Full Text] [Related]
37. [Penetration of ultrasonic acqueous mist into the bronchial tree. A study by means or radiotechnetium]. Marabini A; Franchi R; Mastella G Fracastoro; 1970; 63(3):463-76. PubMed ID: 5517023 [No Abstract] [Full Text] [Related]
38. Acute and long-term amiloride inhalation in cystic fibrosis lung disease. A rational approach to cystic fibrosis therapy. App EM; King M; Helfesrieder R; Köhler D; Matthys H Am Rev Respir Dis; 1990 Mar; 141(3):605-12. PubMed ID: 2310093 [TBL] [Abstract][Full Text] [Related]
39. Mechanical airway clearance using the frequencer electro-acoustical transducer in cystic fibrosis. Cantin AM; Bacon M; Berthiaume Y Clin Invest Med; 2006 Jun; 29(3):159-65. PubMed ID: 17058435 [TBL] [Abstract][Full Text] [Related]
40. Effect of tolazoline hydrochloride on sputum viscosity in cystic fibrosis. Feather EA; Russell G Thorax; 1970 Nov; 25(6):732-6. PubMed ID: 5494682 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]